4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Olema Pharmaceuticals, Inc. (OLMA) operates in the Biotechnology industry and is headquartered in San Francisco, United States with about 137 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, OLMA reported $0M in revenue and ($162M) in net income.
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($179M) | ($142M) | ($105M) | ($107M) | — |
| Net Income | ($162M) | ($130M) | ($97M) | ($105M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($58M) | ($50M) | ($46M) | ($48M) | ($35M) |
| Net Income | ($53M) | ($46M) | ($42M) | ($44M) | ($30M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $533M | $451M | $277M | $216M | — |
| Total Liabilities | $55M | $42M | $23M | $18M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive OLMA viewer.
About TickerBase · Data methodology & sources